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The chromosomal passenger complex (CPC)—composed of Aurora B kinase,
Borealin, Survivin and INCENP—surveys the fidelity of genome segregation
throughout cell division. The CPC has been proposed to prevent polyploidy by
controlling the final separation (known as abscission) of the two daughter cells
via regulation of the ESCRT-III CHMP4C component. The molecular details
are, however, still unclear. Using atomic force microscopy, we show that
CHMP4C binds to and remodels membranes in vitro. Borealin prevents
the association of CHMP4C with membranes, whereas Aurora B interferes
with CHMP4C’s membrane remodelling activity. Moreover, we show that
CHMP4C phosphorylation is not required for its assembly into spiral filaments
at the abscission site and that two distinctly localized pools of phosphorylated
CHMP4C exist during cytokinesis. We also characterized the CHMP4C interac-
tome in telophase cells and show that the centralspindlin complex associates
preferentially with unphosphorylated CHMP4C in cytokinesis. Our findings
indicate that gradual dephosphorylation of CHMP4C triggers a ‘relay’ mechan-
ism between the CPC and centralspindlin that regulates the timely distribution
and activation of CHMP4C for the execution of abscission.
1. Introduction
Cytokinesis is a rapid and robust process that ensures the faithful segregation of
genomic and cytoplasmic contents into the two nascent daughter cells at the end
of cell division. Failure in this final step of cell division leads to the formation of
polyploid cells and has been associated with several genetic diseases, including
cancer [1,2]. Cytokinesis progresses through a series of sequential steps orchestrated
by several proteins and protein complexes in a very precise order. After anaphase
onset, the mitotic spindle is reorganized into an array of antiparallel and interdigi-
tating microtubules, called the central spindle. The plus ends of central spindle
microtubules overlap in a region called the spindle midzone. Signals from the cen-
tral spindle and astral microtubules position the cleavage plane and trigger the
formation of an actomyosin contractile ring that drives the ingression of a cleavage
furrow [1]. Furrow ingression compacts central spindlemicrotubules andultimately
forms an intercellular bridge,which contains at its centre an organelle, themidbody,
composed of several proteins and protein complexes responsible for the proper
execution and timing of abscission [3,4]. All these proteins display a very stereo-
typical arrangement at distinct regions of the midbody, which appears to be
crucial for the late stages of cytokinesis [3–6]. Various terms have been used to
describe the different regions of the midbody; in this paper, we use the terminol-
ogy of D’Avino & Capalbo [3]. In short, the midbody can be divided into two
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2major regions: the ‘Flemming body’, which corresponds to the
central bulge of the midbody containing overlapping microtu-
bule plus ends and various central spindle and contractile ring
components, and the ‘midbody arms’, which represent the
regions flanking the Flemming body [3]. One protein complex
that plays a key role in the assembly and function of the mid-
body is the chromosomal passenger complex (CPC) [3,6,7].
This complex, composed of a kinase component, Aurora B,
the scaffolding subunit inner centromeric protein (INCENP),
Borealin and Survivin, also has a key role in surveying the
proper segregation of genomes throughout mitosis [8].
In early mitosis, the CPC is responsible for monitoring and
correcting the attachments of microtubules to kinetochores,
whereas later in cytokinesis it prevents the final abscission of
the two daughter cells in the presence of lagging chromatin
at the cleavage site, thereby avoiding the formation of geneti-
cally abnormal daughter cells [7,8]. The Snf7 component of
the endosomal sorting complex required for transport III
(ESCRT-III) has been identified as one the CPC’s targets in
abscission [9,10]. ESCRT proteins are evolutionarily conserved
and known for catalysing membrane fission events in several
topologically similar events such as abscission, virus budding
and the sorting of receptors into vesicles that bud into the
lumen of the endosome, creating multivesicular bodies
(MVBs) [11]. The ESCRT-III complex is the core machinery
that mediates membrane deformation and fission events
during these events [12], and Snf7 components (known as
CHMP4 proteins in humans) have been shown to form spiral
filaments that appear to remodel and constrict the membrane
in order to create the abscission site [13]. TheCPChas been pro-
posed to regulate abscission timing through direct interaction
with the Snf7 components in both Drosophila and humans
[9,10]. In human cells, Borealin directly interacts with all
three CHMP4 paralogues, CHMP4A, CHMP4B and
CHMP4C, and Aurora B phosphorylates the terminal tail of
CHMP4C [9,10], a region known to regulate CHMP4C’s ability
to formpolymers and associatewithmembranes [14]. Based on
this evidence, two different models have been proposed for the
regulation of CHMP4 proteins by the CPC. Carlton et al. [10]
proposed that Aurora B phosphorylation promotes CHMP4C
translocation to the midbody ring, where this ESCRT-III
component inhibits abscission. By contrast, we proposed
that CPC controls abscission through inhibition of CHMP4
polymerization and membrane association using two concur-
rent mechanisms: interaction of its Borealin component with
all three CHMP4 proteins and phosphorylation of CHMP4C
by Aurora B [9]. These two concomitant events could preclude
the formation of the ESCRT-III filaments essential for the for-
mation of the constriction that physically separates the two
daughter cells. In this model, CHMP4 proteins can assemble
into spiral filaments only after CPC removal from themidbody.
Overall, the CPC-mediated regulation of ESCRT-III has been
suggested to act as a surveillance mechanism that prevents
abscission in the presence of DNA at the cleavage site
[9,10,15]. However, molecular evidence in support of either
model is still lacking, and the mechanistic details of how the
CPC controls CHMP4 proteins in abscission are still unclear.
Here, we used atomic force microscopy (AFM) to show that
purified CHMP4C binds to highly curvedmembranes and pro-
motes the closure of membrane gaps. Interaction with Borealin
prevents the association of CHMP4C with membranes,
whereas Aurora B interferes with CHMP4C’s ability to close
membrane gaps. Furthermore, we show that two differentpopulations of Aurora B-phosphorylated CHMP4C exist,
with distinct localization patterns, and that Aurora B phos-
phorylation is not required for the assembly of CHMP4C
spiral filaments at the abscission site. Finally, we show that
CHMP4C interacts directly with the kinesin component of
the centralspindlin complex and that this interaction is
favoured in the absence of Aurora B phosphorylation. Our
findings support a model in which the CPC and centralspin-
dlin cooperate to regulate the activity and localization of
CHMP4C during cytokinesis.2. Results
2.1. The ability of CHMP4C to bind to and remodel
membranes is regulated by the chromosomal
passenger complex
We previously showed that the Borealin central region (residues
110–207) interacts directly with the first 121 amino acids of
CHMP4C and that Aurora B phosphorylates this ESCRT-III sub-
unit at three serines in its C terminus: S210, S214 and S215 [9].
To investigate whether the CPC has any role in regulating the
ability of CHMP4C to associate with and remodel membranes,
we employed AFM, which has already been successfully used
to visualize the ESCRT-III machinery on supported lipid bilayers
at nanometre resolution [16]. On mica surfaces, without lipid
bilayers, CHMP4C alone was visualized as both single particles
and filaments (electronic supplementary material, figure S1a),
indicating that CHMP4C can form polymers in vitro. As Borealin
cannot be purified alone, we used in our experiments a purified
recombinant ‘CPC mini-complex’ (hereafter called mini-CPC),
composed only of Borealin, Survivin and the first 58 amino
acids of INCENP (thus lacking the phosphorylation module:
Aurora B and the INCENP activation segment) [17]. Notably,
the presence of Survivin and INCENP1–58 will not affect
our results because they both interact with the N-terminus of
Borealin [17], whereas CHMP4C binds to the Borealin central
region [9]. The mini-CPC often appeared as three-pearl strings
(electronic supplementary material, figure S1b), but when com-
bined with CHMP4C, large globular complexes were observed
and no CHMP4C filaments formed (electronic supplementary
material, figure S1c). These results indicate that binding of
CHMP4C to the mini-CPC prevents CHMP4C polymerization,
in agreement with our model [9]. On a lipid bilayer composed
of 70% L-a-phosphatidylcholine (PC), 15% 1,2-dioleoyl-sn-
glycero-phosphoethanolamine (DOPE) and 15% 1,2-dioleoyl-
sn-glycero-3-[phospho-L-serine] (DOPS), CHMP4C filaments
assembled specifically at highly curved membranes at the
edges of bilayer gaps (figure 1a–c). In addition, these filaments
appeared to promote the closure of membrane gaps over time
(figure 1d,n; see also electronic supplementary material, movie
S1). This behaviour is similar to that observed previously for
the C. elegans CHMP4B homologue [16], but in our system,
human CHMP4C did not require the presence of other ESCRT
proteins. We noted that the thickness of a plain bilayer was
measured at 4.28+0.13 nm (n¼ 5) (electronic supplementary
material, figure S2a), similar to what has been previously
reported [16],whereas the average apparent thickness of a bilayer
after incubation with CHMP4C was approximately 2 nm (elec-
tronic supplementary material, figure S2b). The decrease in the
measured thickness of the bilayer can be attributed mainly to
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Figure 1. (Overleaf.) The CPC affects the ability of CHMP4C to bind to and remodel membranes in vitro. (a) Schematic of a lipid bilayer (yellow) assembled on a mica surface
(brown). The central portion of the bilayer is flat, whereas the edges of the bilayer are highly curved. (b) Zoomed AFM image of a lipid bilayer incubated with CHMP4C. A height
bar is shown on the right. Scale bar, 20 nm. (c) Height relative to the mica surface is plotted along the dotted line shown in (b). The position of the arrowhead (at the bilayer
edge) along the line is also shown in (b), which is raised above the height of the bilayer surface, indicating the presence of protein. (d ) Sequential AFM images of the same lipid
bilayer in the presence of CHMP4C. A height bar is shown on the right. Scale bar, 200 nm. (e) Zoomed AFM image of a lipid bilayer incubated with CHMP4C þ mini-CPC. A
height bar is shown on the right. Scale bar, 50 nm. (f ) Height relative to the mica surface is plotted along the dotted line shown in (e). The position of the arrowhead (at the
bilayer edge) along the line is also shown in (e), which shows no rise at the bilayer edge, indicating no protein interaction with the bilayer but rather a concentration of protein
on the mica surface. (g) Sequential AFM images of the same lipid bilayer in the presence of CHMP4C þ mini-CPC. A height bar is shown on the right. Scale bar, 200 nm. (h)
Zoomed AFM image of a lipid bilayer incubatedwith CHMP4Cþ Aurora B þ ATP. A height bar is shown on the right. Scale bar, 50 nm. (i) Height relative to themica surface is
plotted along the dotted line shown in (h). The position of the arrowhead (at the bilayer edge) along the line is also shown in (h), which is raised above the height of the bilayer
surface, indicating the presence of protein. ( j ) Sequential AFM images of the same lipid bilayer in the presence of CHMP4C þ Aurora B þ ATP. A height bar is shown on the
right. Scale bar, 200 nm. (k) Zoomed AFM image of a lipid bilayer incubatedwith CHMP4C and Aurora B. A height bar is shown on the right. Scale bar, 20 nm. (l ) Height relative
to themica surface is plotted along the dotted line shown in (k). The position of the arrowhead (at the bilayer edge) along the line is also shown in (k), which is raised above the
height of the bilayer surface, indicating the presence of protein. (m) Sequential AFM images of the same supported lipid bilayer in the presence of CHMP4Cþ Aurora B. A
height bar is shown on the right. The arrows mark membrane gaps that started closing and then collapsed. Scale bar, 200 nm. (n) Variation in the percentage of the mica
surface coated with lipid bilayer in the presence of various proteins.
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4the presence of protein or small lipid fragments in themembrane
gaps. Additionally, as the scanning usually continued over seve-
ral minutes and the membrane gaps began to close, there was a
progressive reduction in the measured bilayer thickness, indicat-
ing possible thinning/stretching of the bilayer. As expected, the
mini-CPCalone did not showanyspecificmembrane association
or remodelling activity (data not shown). However, its presence
prevented the binding of CHMP4C to the edges of the bilayer
gaps and instead large globular complexes accumulated within
the gaps (figure 1e,f ). As a result, no membrane remodelling
occurred (figure 1g,n; see also electronic supplementarymaterial,
movie S2). These results indicate that the interaction of Borealin
with CHMP4C impedes the association of this ESCRT-III com-
ponent with the membrane, exactly as predicted by our model
[9]. We then incubated CHMP4C with active recombinant
Aurora B and ATP to promote CHMP4C phosphorylation, and
then observed its behaviour on lipid bilayers. In these conditions,
CHMP4Cwas still able to associatewith the highly curvedmem-
brane at the edges of lipid bilayer gaps (figure 1h,i), but no
progressive gap closure was observed (figure 1j,n; see also elec-
tronic supplementary material, movie S3). Interestingly, after
incubating CHMP4C with Aurora B in the absence of ATP, we
observed that somemembrane gaps began to close, but then col-
lapsed (figure 1m,n, arrows; see also electronic supplementary
material, movie S4). Together, these results indicate that Aurora
B phosphorylation inhibits the membrane remodelling activity
of CHMP4C, but not its association with highly curved mem-
branes. However, without its kinase activity Aurora B could
still partially interfere with CHMP4C activity, which is consist-
ent with the observation that recombinant Aurora B could pull
down CHMP4C from cell extracts [10], and with our in vitro
pull-down assays indicating that bacterially purified GST-
tagged Aurora B can interact with in vitro translated CHMP4C
(electronic supplementary material, figure S3).
2.2. Aurora B phosphorylation is not necessary for the
formation of CHMP4C spirals at the abscission site
To investigate the role ofAurora B phosphorylation on the ability
of CHMP4C to form polymers in vivo, we generated HeLa
cell lines stably expressing three different Flag-tagged
RNAi-resistant versions of CHMP4C: wild-type (WT), a non-
phosphorylatable mutant S210A and a mutant that cannot be
phosphorylated at any of these three serine residues, S210A,
S214A and S215A, dubbed ‘StripleA’. As our previous resultsindicated that overexpression of all these CHMP4C proteins
caused an increase in cytokinesis failure [9], we generated several
independentmonoclonal cell lines for each construct and specifi-
cally selected those that did not show a major increase in the
number of multinucleate cells (electronic supplementary
material, figure S4). All these Flag::CHMP4C proteins localized
to the Flemming body and were able to form spiral filaments at
the abscission site (figure 2a–c), indicating that preventing
phosphorylation of these residues by Aurora B did not affect
CHMP4C polymerization and its association with membranes,
in complete agreement with our findings in vitro (see §2.1).
Consistent with this, abscission was not impaired in these cell
lines (data not shown). Interestingly, we found that while
Flag::CHMP4Cproteins always formedacontinuous spiral struc-
ture that extended fromthemidbody core to the constriction zone
(figure 2a–d), CHMP4B showed two distinct localizations, at the
Flemming body and at the constriction zone (figure 2d),
suggesting that different CHMP4 proteins might play distinct
roles during abscission.
2.3. Two populations of Aurora B-phosphorylated
CHMP4C exist with distinct localization patterns
during cytokinesis
Our previous data indicated that phosphomimetic CHMP4C
mutants did not behave differently from their phosphodead
counterparts with respect to their localization and effect
on cytokinesis [9], suggesting that they do not reflect the
localization and function of phosphorylated CHMP4C. There-
fore, to elucidate the role of CHMP4C phosphorylation by
Aurora B in cells, we generated two CHMP4C phospho-
specific antibodies: one that specifically recognized the form
phosphorylated at all three residues, S210, S214 and S215
(tri-phospho) [9], and another specific for the form phosphory-
lated only at S210 (mono-phospho). These antibodies were
extensively validated to show that they recognize only their
specific phosphorylated variant (electronic supplementary
material, figure S5) [9] and that their signals disappear after
depletion of CHMP4C (3). These phospho antibodies dis-
played different localization patterns during cytokinesis. We
found that in metaphase, the tri-phospho CHMP4C antibody
accumulated at the plus ends of kinetochore microtubules
(electronic supplementary material, figure S6). A signal was
also observed on centrosomes, but was not specific because it
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5did not disappear after CHMP4C depletion (electronic sup-
plementary material, figure S6 and data not shown). After
anaphase onset, tri-phospho CHMP4C localized to the spindle
midzone in early telophase, accumulated at the midbody arms
after furrow ingression, and then disappeared in late telophase
after the ‘bow tie’ stage (figure 3a) [1,3]. This spatial and tem-
poral localization pattern during cytokinesis matches exactly
that of the CPC, and indeed, tri-phospho CHMP4C and
Aurora B perfectly co-localized during telophase (figure 3b).
By contrast, mono-phospho CHMP4C did not show any
specific staining before anaphase onset (data not shown), but
localized to the spindle midzone in early telophase and then
specifically accumulated at the Flemming body, where it per-
sisted throughout cytokinesis until abscission, even after the
CPC disappeared (figure 3d,e). Immunostaining on isolated
midbodies confirmed that tri-phospho CHMP4C accumulated
at the midbody arms, whereas mono-phospho CHMP4C
formed a ring around the Flemming body (figure 3a,d ). The
signals of the two antibodies were specific for CHMP4C
because they disappeared after its depletion (figure 3c,f ).
The perfect co-localization of tri-phospho CHMP4C with
the CPC in cytokinesis and the direct interaction between
CHMP4C and two CPC components, Borealin and Aurora B
(electronic supplementary material, figure S2) [9,10], sug-
gested that the localization of this phosphorylated variant
of CHMP4C could depend on the CPC. To investigate the
role of the CPC in CHMP4C localization in cytokinesis, we
prevented the translocation of this complex to the spindlemidzone by depleting the kinesin KIF20A/MKLP2 [18]. No
accumulation of tri-phospho CHMP4C at the midbody arms
was observed after KIF20A RNAi (figure 4a), while only a
slight reduction of the mono-phospho CHMP4C signal was
observed, which was not statistically significant (figure 4b,c).
To determine whether tri-phospho CHMP4C localization
required the whole CPC or just Aurora B, we tested if a chi-
maera composed of the microtubule binding domain of the
spindle midzone protein PRC1 coupled with an Aurora B
kinase module (dubbed Baronase and comprising a truncated
form ofAurora B and the INCENPactivating region) [19] could
rescue tri-phospho CHMP4C localization after KIF20A
depletion. No accumulation of tri-phospho CHMP4C at the
midbody arms was observed after KIF20A depletion in cells
expressing the PRC1::Baronase chimaera (figure 4d), indicating
that the localization of this phosphorylated CHMP4C variant
to the midbody arms requires the whole CPC and probably
its interaction with Borealin.
Together, these results indicate that at least two distinct
populations of phosphorylated CHMP4C exist: one pool is
phosphorylated at all three serine residues (S210, S214 and
S215) at the midbody arms where Aurora B activity is high,
whereas the other is phosphorylated only at S210—the stron-
gest phosphorylation site—at the midbody ring, more distant
from Aurora B activity. In addition, they also suggest that the
localization of tri-phospho CHMP4C at the midbody arms
requires the whole CPC and that dephosphorylation at S214
and S215, rather than phosphorylation at S210, may trigger
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as described [1,3].
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6CHMP4C translocation to the midbody ring. It is also note-
worthy that neither of the two CHMP4C phospho-antibodies
identified the spiral-like structures observed with Flag-
tagged CHMP4C proteins, suggesting that phosphorylated
CHMP4C is not present in these spiral filaments, which have
been proposed to mediate abscission.
Our findings therefore reveal that Aurora B phosphoryl-
ation regulates CHMP4C localization, but not its ability to
polymerize and form spiral filaments at the abscission site
in cytokinesis.
2.4. The centralspindlin complex associates
preferentially with the low- and unphosphorylated
forms of CHMP4C during cytokinesis
The localization of Flag-CHMP4C and mono-phospho
CHMP4C to the Flemming body and the requirement of the
CPC only for the localization of tri-phospho CHMP4C
suggested that other factors might be involved in the dynamicdistribution of this ESCRT-III component during cytokinesis.
To examine this, we employed our HeLa cell line expressing
Flag::CHMP4C (WT) to isolate proteins that associate with
CHMP4C during cytokinesis by affinity purification coupled
with mass spectrometry (AP-MS). We isolated a total of 693
proteins that were specifically pulled down by Flag::CHMP4C,
but not by Flag alone, in HeLa cells synchronized in telophase
(figure 5a; electronic supplementary material, table S1).
Among the isolated proteins, we found, as expected, some
previously identified interactors, such as CHMP4B, ALIX
(ALG2-interacting protein X, also known as programmed cell
death 6 interacting protein, PDCD6IP), and three of the four
CPC components—Aurora B, Borealin and INCENP—but
also some novel partners, including the two components of
the centralspindlin complex, KIF23/MKLP1 and MgcRac-
GAP/RacGAP1 (figure 5b; electronic supplementary
material, table S1). Centralspindlin is known to play many
essential roles during cytokinesis [20,21], including recruit-
ing the protein Cep55 to the midbody [22], which, in turn,
has been reported to be necessary for the recruitment of
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Figure 4. The CPC is required for the localization of tri-phospho CHMP4C at the cleavage site. (a) HeLa Kyoto cells were treated with siRNAs directed against either a
random sequence (control) or KIF20A/MKLP2 and after 48 h fixed and stained to detect tri-phospho CHMP4C (red), tubulin (green) and DNA (blue). Insets show two
times magnifications of the central spindle and midbody. Scale bars, 10 mm. (b) HeLa Kyoto cells were treated with siRNAs directed against either a random
sequence (control) or KIF20A/MKLP2 and after 48 h fixed and stained to detect mono-phospho CHMP4C (red), tubulin (green) and DNA (blue). Insets show
two times magnifications of the central spindle and midbody. Scale bars, 10 mm. (c) Box plot shows the quantification of mono-phospho CHMP4C fluorescence
levels at the midbody calculated as described previously [6]; see also Material and methods. More than 50 cells from three separate experiments were counted for
each sample. AU, arbitrary unit. p ¼ 0.8 (Student’s t-test). (d ) HeLa Kyoto cells carrying a doxycycline-inducible GFP-tagged PRC1-Baronase transgene were treated
with siRNAs directed against either a random sequence (control) or KIF20A and after 24 h incubated in 2 mM thymidine for a further 20 h. Cells were washed and
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Scale bars, 10 mm. In all experiments, the shape and thickness of microtubule bundles were used as criteria to stage telophase cells as described [1,3].
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7CHMP4Cvia the intermediateALIX [23]. Unexpectedly, Cep55
was not identified in our AP-MS purification, although it is
possible that this was simply because of MS limitations. Con-
sistent with the AP-MS findings, we found that MKLP1 co-
localized with Flag::CHMP4C and mono-phospho CHMP4C,
but not tri-phospho CHMP4C, at the Flemming body in late
cytokinesis (figure 5c–e). Furthermore, to confirm the inter-
action between CHMP4C and centralspindlin in vivo we
performed a reciprocal pull-down experiment by transfecting
a monoclonal HeLa cell line stably expressing MKLP1::GFP
[24] with Flag::CHMP4C-WT, Flag::CHMP4C-S210A and
Flag::CHMP4C-StripleA. Immunoprecipitations using GFP
nanobodies indicated that, in synchronized telophase cells,
MKLP1::GFP pulled down Flag::CHMP4C-StripleA more effi-
ciently than the other two Flag::CHMP4C proteins (figure 5f ).
Together, these results suggest that, in telophase cells, cen-
tralspindlin associates preferentially with the low- and
unphosphorylated forms of CHMP4C.2.5. MKLP1 binds directly to CHMP4C and is required
for its localization to the midbody
To assess whether MKLP1 could directly bind to CHMP4C,
we purified recombinant MKLP1 fragments tagged with gluta-
thione-S-transferase (GST) from bacteria and tested their
ability to pull down in vitro translated and radiolabelled
CHMP4C polypeptides (figure 6a). The N-terminal basic halfof CHMP4C, which contains the first two a-helices (aa 1–121),
was pulled down very efficiently by the MKLP1 central region
containing the coiled coil domain (aa 437–619), and less effi-
ciently by an MKLP1 polypeptide encompassing part of the
coiled coil domain and the whole tail region (aa 590–856;
figure 6b). No interaction was observed between any MKLP1
fragment and the C-terminal half of CHMP4C (figure 6b). Reci-
procal pull-down assays usingGST-taggedCHMP4C fragments
confirmed a strong interaction between the N-terminal half of
CHMP4C and the C-terminal region of MKLP1 (figure 6c).
We then investigated whether MKLP1 was required for the
localization of CHMP4C during cytokinesis. Tri-phospho and
mono-phospho CHMP4C did not accumulate at the central
spindle in MKLP1 siRNA mid-telophase cells (figure 6d,e),
suggesting that centralspindlin is necessary for the localization
of CHMP4C. However, as already known, microtubules failed
to assemble into a robust and organized central spindle after
MKLP1 depletion (figure 6d,e), raising the possibility that the
absence of CHMP4C at the central spindle could be a secondary,
indirect effect. In the few MKLP1 RNAi cells that managed
to complete furrow ingression, tri-phospho CHMP4C persisted
much longer than in control cells, although it failed to form
twodistinct bands (figure 6d). By contrast, in these late telophase
MKLP1 RNAi cells, mono-phospho CHMP4Cwas either absent
or failed to form a ring or disc-like structure, its localization
appearing similar to that of tri-phospho CHMP4C (figure 6e).
To conclude, our results indicate that MKLP1 interacts
directly with the N-terminus of CHMP4C and that this kinesin
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9seems necessary for the proper localization of CHMP4C,
and in particular for the timely disappearance of tri-phospho
CHMP4C and accumulation and correct distribution of
mono-phospho CHMP4C in late cytokinesis (figure 6d,e).3. Discussion
The identification of the CPC as a key factor in surveying
abscission in eukaryotes [15,25] and the discovery of the
ESCRT-III CHMP4 components as its possible targets in this
process [9,10] have begun to unravel some of the mechanisms
that regulate the fidelity and timing of the final separation of
the two daughter cells during cytokinesis. However, themolecular details are still missing, and our study provides
novel crucial insights into this process.
First, our results strongly support and expand our pre-
vious model, which posited that the CPC could control the
ability of CHMP4C to polymerize and interact with mem-
branes using two concurrent mechanisms [9]. Consistent
with our hypothesis, AFM results clearly demonstrated that
the presence of a minimal CPC complex, without Aurora B,
precluded the interaction of CHMP4C with membranes,
whereas Aurora B phosphorylation interfered solely with
CHMP4C’s membrane remodelling activity (figure 1). Inter-
estingly, Aurora B could also partially inhibit CHMP4C in
the absence of its kinase activity, which adds a further level
of control of CHMP4C by the CPC.
mid telophase late telophase abscission
midbody
midbody
remnant
intercellular bridge
centralspindlin CPC triphospho CHMP4C mono-phospho CHMP4C CHMP4C CHMP4C filaments
Figure 7. A relay mechanism for the control of CHMP4C by the CPC and centralspindlin. The diagram illustrates the distribution of different forms of CHMP4C and
their association with the CPC and centralspindlin at sequential stages of cytokinesis, from mid-telophase to abscission. Full details are given in the text.
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10Second, it is noteworthy that our AFM results also prove,
for the first time, that a single CHMP4 protein has the ability
to bind to and remodel membranes in vitro in the absence of
any other ESCRT-III component (figure 1). Our result,
together with the observations that CHMP4C accumulates
at the cleavage site earlier than other CHMP4 paralogues
(figure 3) [10] and is able to assemble into a continuous
spiral structure in abscission (figure 2), highlights the unique-
ness of CHMP4C. It may also explain why this CHMP4
paralogue is the only one tightly controlled by the CPC via
Aurora B phosphorylation [9,10].
Finally, our study identifies two pools of phosphorylated
CHMP4C with distinct spatial and temporal localization pat-
terns that appear to depend on their interaction with either
the CPC or centralspindlin. Together, our data indicate
that centralspindlin in vivo associates preferentially with the
low- and unphosphorylated forms of CHMP4C, whereas
the localization of tri-phospho CHMP4C to the midbody
arms depends primarily on the CPC (figures 3–5). Based on
these results, we would like to propose that a ‘relay’ mechan-
ism between the CPC and centralspindlin could control the
translocation of CHMP4C from the midbody arms to the Flem-
ming body at the end of cytokinesis (figure 7). In this model, at
the metaphase–anaphase transition—when Aurora B activity
is high and the activity of counteracting phosphatases is
low—CHMP4C is bound to the CPC (through its interaction
with Borealin) and phosphorylated at all three serine residues
by Aurora B. During telophase, the combined increase in phos-
phatase activity and gradual degradation of the CPC would
lead to the progressive de-phosphorylation of CHMP4C,
removing first the phosphates at S214 and S215 and then at
S210. These changes would release CHMP4C from its associ-
ation with the CPC and promote its interaction with
centralspindlin, causing the translocation of this ESCRT-III
component from the midbody arms to the Flemming body,
in preparation for abscission (figure 7).
In sum, our findings indicate that CHMP4C plays an
active role in membrane deformation during abscission and
that its activity and localization are finely regulated by both
the CPC and centralspindlin. They do not support thehypothesis that CHMP4C could act as a ‘brake’ by preventing
the assembly of a productive ESCRT-III abscission complex
[10]. However, the data reported by Carlton et al. [10], that
CHMP4C depletion induces premature abscission and
that Aurora B phosphorylation regulates CHMP4C during
abscission, are compatible with our model. Some questions,
however, remain unanswered. For example, why did mono-
phospho CHMP4C not disappear after preventing the
translocation of the CPC to the central spindle and persisted
after degradation of the CPC (figures 3 and 4)? One possi-
bility is that phosphorylation at S210 could somehow be
protected from the action of phosphatases. Alternatively,
CHMP4C could be phosphorylated at S210 also by other
kinases that have been described to target ESCRT-III subunits
in cytokinesis [26–28]. The identification of the phospha-
tase(s) that dephosphorylate CHMP4C in late cytokinesis
will be important to further confirm and clarify our model.
Recent studies have indicated that members of the PP2A
family antagonize Aurora B phosphorylation in both meta-
phase and telophase [29–31]. The catalytic (PP2CA) and
regulatory subunit A (PPP2R1A) of PP2A were identified in
our AP-MS experiment (electronic supplementary material,
table S1), thus making this phosphatase a very strong candi-
date. However, the catalytic (PPP1CA) and regulatory
(PPP1R12A) subunits of the PP1 family were also found (elec-
tronic supplementary material, table S1). As PP1 phosphatases
have also been shown to antagonizeAurora kinases [32], future
investigations are required to fully understand the role of
different phosphatases in CHMP4C regulation.
The evidence that MKLP1 interacts with the N-terminal
half of CHMP4C, which is known to be required for
CHMP4C polymerization and association with membranes
[14], suggests that MKLP1 is likely to have the same inhibitory
activity as Borealin. This raises the important question of what
could be the signal that triggers the release of CHMP4C from
MKLP1 and its assembly into the spiral filaments that promote
abscission. As a lag exists between the disappearance of the
CPC and the formation of CHMP4C spirals in normal con-
ditions (figures 3 and 4) [3,7], we speculate that other signals
probably exist in addition to the gradual degradation and
rsob.royalsocietypublishing.org
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11inactivation of the CPC. A simple hypothesis could be that
CHMP4C release requires the presence of one or more factors
that are recruited to the midbody later, just before abscission.
Two such factors could be CHMP4B—which has been
described to localize to the midbody immediately before
abscission [10]—and Cep55, whose interaction with MKLP1
is inhibited by Plk1 phosphorylation until late in cytokinesis
[33]. Other proteins known to interact with CHMP4C during
cytokinesis, such as ALIX, ANCHR and Vps4 [23,34,35],
could also be involved, and future studies will be necessary
to integrate all these factors into a comprehensive mechanistic
model for ESCRT-mediated abscission.en
Biol.6:1602484. Material and methods
4.1. Molecular biology and protein expression
Plasmids harbouring CHMP4C non-phosphorylatable
mutants have been described previously [9]. The open reading
frame (ORF) encoding CHMP4C was amplified by PCR using
Accuprime polymerase (Invitrogen) and primers containing
attB flanking sequences for Gateway technology. The PCR
product was purified and introduced into a pDONR221 plas-
mid (Invitrogen) to generate CHMP4C entry vectors. Then, to
generate siRNAi-resistant CHMP4C WT and mutant variants,
QuikChange lightning site-directed mutagenesis kit was used
(Agilent Technologies). Expression vectors for siRNA resistant
Flag::CHMP4C-WT and mutant variants were generated,
using recombination with pCMV-Tet02-NtermMycFlag
destination vector.
For purification of recombinant CHMP4C, its full-length
ORF was cloned into a pET-His6-msfGFP cloning vector
(Addgene) as a TEV-cleavable His-tagged protein. The pET-
His6-msfGFP-CHMP4Cvectorwastransformed intoEscherichia
coli BL21 Gold competent cells and grown at 378C in Super
Broth-medium containing ampicillin until OD600 reached
1. The culture was induced overnight at 188C with IPTG at a
final concentration of 0.35 mM. Cells were resuspended in a
lysis buffer (20 mMTris–HCl pH 8, 750 mMNaCl, 35 mM imi-
dazole and 2 mM 2-mercaptoethanol) and lysed by sonication.
The His6-GFP::CHMP4C protein was purified by affinity
chromatography using a Ni-NTA column (GE Healthcare).
The protein-bound column was washed with lysis buffer fol-
lowed by 20 mM Tris–HCl pH 8, 1000 mMNaCl, 50 mM KCl,
10 mMMgCl2, 2 mMATP, 35 mM imidazole and 2 mM 2-mer-
captoethanol. The proteinwas elutedwith 20 mMTris–HCl pH
8, 750 mMNaCl, 400 mMimidazole and2 mM2-mercaptoetha-
nol. Thepooled eluted fractionswere dialysed overnight against
20 mM Tris–HCl pH 8, 750 mM NaCl and 2 mM DTT while
cleaving with 500 mg of TEV. Concentrated protein was
loaded onto a Superdex 200 increase column (GE Healthcare)
equilibrated with 20 mM Tris–HCl pH 8, 200 mM NaCl and
2 mM DTT. The purity of the sample was analysed by 15%
SDS–PAGE stained with Coomassie blue.
A similar procedure was used to purify the CPC mini-
complex (Survivin full-length, Borealin full-length and
INCENP 1–57). Borealin was cloned as a TEV-cleavable His-
tagged protein in a pETM vector, Survivin as a 3C-cleavable
GFP-tagged protein in a pRSET vector (Thermo Fisher) and
INCENP 1–57 as an untagged protein in a pMCNcs vector.
Proteins were co-expressed in BL21 pLysS with an overnight
induction at 188C. Cells were lysed in 25 mM HEPES pH 7.5,500 mM NaCl, 25 mM imidazole and 2 mM 2-mercaptoetha-
nol and complex purified by affinity chromatography
followed by size exclusion chromatography as above.
4.2. Atomic force microscopy
AFM imaging was performed using a Bruker dimension Fast-
Scan instrument. All imaging was conducted under fluid,
using FastScan D cantilevers (Bruker). Their resonant frequen-
cies under fluid were 110–140 kHz, and the actual scanning
frequencies were approximately 5% below the maximal reson-
ance peak. Lipid mixtures containing 70% PC, 15% DOPE and
15%DOPSwere dried under nitrogen and hydrated in Biotech-
nology performance-certified water overnight. Suspensions
were probe-sonicated at an amplitude of 10 mA until the mix-
ture became transparent. Liposomes were incubated in the
presence or absence of proteins for 30 min and then placed
on freshly cleavedmica. In each case, 40 ml of the liposomemix-
ture and an equal volume of buffer (20 mMTris, pH 8, 100 mM
NaCl and 1 mMMgCl2) were applied to the mica surface. The
mica was washed three times with the same buffer and placed
in the fluid cell of the atomic force microscope. The assembled
lipid bilayer was immersed in 150 ml of buffer, and all imaging
was performed at room temperature. AFM images were
acquired at a rate of four frames per minute and plane-fitted
to remove tilt. Each scan linewas fitted to a first-order equation.
CHMP4C was phosphorylated in vitro using recombinant
Aurora B (Life Technologies). The assay contained kinase
buffer (20 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT,
0.1 mM cold ATP) and with or without 190 ng of recombi-
nant AuroraB (Life Technologies). Reactions were incubated
at 308C for 30 min, before incubation with lipids for a further
30 min.
4.3. Cell culture, siRNA transfection, drug treatments
and generation of stable cell lines
Cell lines stably expressing Flag alone and Flag::CHMP4C
constructs were generated by plating 2 106 HeLa Kyoto cells
in a 100 mm culture dish and transfecting with 19 mg of the
appropriate DNA, using FuGENE HD transfection reagent
(Promega) for 48 h. Cells were subsequently washed with phos-
phate-buffered saline (PBS) and cultured in complete selective
medium containing 0.4 mg ml21 puromycin for approximately
two weeks until colonies became visible. Individual colonies
were picked, cultured under resistance and tested for expression
of the construct by western blot and immunofluorescence.
HeLa Kyoto cells expressing the PRC1::Baronase chi-
maera were a gift of F. Barr (University of Oxford) and
were maintained in DMEM (Invitrogen) containing 10%
fetal bovine serum (FBS, Sigma) and 1% penicillin/strepto-
mycin (Invitrogen) at 378C and 5% CO2. To express the
PRC1::Baronase construct, cells were treated with 1 mg ml21
doxycycline for 10 h. The MKLP1::GFP cell line was a gift
of M. Mishima (University of Warwick) [24].
For RNA interference, the following siRNAs were used:
scrambled sequence control: 50-AACGTACGCGGAATACT
TCGA-30;
CHMP4C: 50-CTCACTCAGATTGATGGCACA-30;
KIF20A/MKLP2: 50-AACCACCTATGTAATCTCATG-30;
KIF23/MKLP1: 50-GCAGUCUUCCAGGUCAUCU-30.
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12Cells were transfected using lipofectamine RNAiMAX
(Invitrogen) following the manufacturer’s instructions.
4.5. Antibodies
CHMP4C phospho-specific antibodies were raised in rabbits
against synthetic CHMP4C peptides encompassing residues
206–220 (TARRSRAASSQRAEEC) and containing either a
phosphorylated serine at position S210 (TARRpSRAASSQ-
RAEEC; mono-phospho CHMP4C) or phosphorylated
serines at position S210, S214 and S215 (TARRpSRAApSpSQ-
RAEEC; triphospho CHMP4C). Sera were first eluted
through a column containing a non-phosphorylated peptide,
and then each antibody was affinity purified using the appro-
priate phosphopeptide. Peptide synthesis, conjugation, rabbit
immunizations, serum production and affinity purification
were carried out by Generon, UK.
Other antibodies used in this study were: mouse mono-
clonal anti a-tubulin (clone DM1A, Sigma, T9026), chicken
polyclonal anti-a-tubulin (Abcam, ab89984), mouse mono-
clonal anti-Flag (clone M2, Sigma, F3165), rabbit polyclonal
anti-Aurora B (Abcam, ab2254), mouse monoclonal anti-
Borealin (clone 1D11-MLB Life Science M147-3), rabbit
polyclonal anti-KIF23/MKLP1 (clone N19, Santa Cruz
Biotechnology, sc-867), rabbit polyclonal anti-CHMP4B, a
gift of Sagona & Stenmark [36]. Peroxidase- and Alexa-fluor-
conjugated secondary antibodies were purchased from Jackson
Laboratories and Thermo, respectively.
4.6. Fluorescence microscopy
HeLa cells were grown on glass coverslips (Menzel-Gla¨ser),
fixed in ice-cold methanol for 10 min, washed three times for
10 min with PBS and incubated in blocking buffer (PBS, 0.5%
[v/v] Triton X-100 and 1% [w/v] BSA) for 1 h at RT. Coverslips
were then incubated overnight at 48C with the primary anti-
bodies, diluted in PBT (PBS, 0.1% [v/v] Triton X-100 and 1%
[w/v] BSA). The following day, coverslips were washed
twice for 5 min in PBT, incubated with secondary antibodies
diluted in PBT for 2 h at RT and then washed twice with PBT
and once with PBS. Coverslips were mounted on SuperFrost
Microscope Slides (VWR) using Vectashield Mounting
Medium containing DAPI (Vector Laboratories). Phenotypes
were scored blind and by at least two people independently.
Midbodies were purified form HeLa Kyoto cells as
described previously [6,9].
The intensity of mono-CHMP4C fluorescence at midbo-
dies was calculated using the formula: mono-CHMP4C
fluorescence ¼ (ICF2 IC)/IC, where ICF is the fluorescence
intensity at the midbodies and IC represents the background
intensity measured within an identical area inside the cyto-
plasm; more than 50 midbodies from at least three separate
experiments were analysed. p-values were calculated using
Student’s t-test.
4.7. Affinity purification and mass spectrometry
Cells (4  107) expressing Flag::CHMP4C WT were synchro-
nized in telophase by a thymidine-nocodazole block-and-
release procedure. They were first arrested in S phase by
adding 2 mM thymidine (Sigma-Aldrich) for 19 h, washed
twice with PBS and released for 5 h in fresh complete
medium. After release, cells were cultured for an additional13 h in fresh complete medium containing 50 ng ml21 nocoda-
zole (Sigma-Aldrich) and then harvested by mitotic shake-off.
Mitotic cells were washed three times with PBS, released in
fresh medium for 1.5 h and incubated for a further 15 min
with the CDK1 inhibitor RO3306 (Calbiochem) at a final
concentration of 10 mM. Cells were then harvested by centrifu-
gation and frozen in liquid nitrogen. The cell pellet was
resuspended in 5 ml of extraction buffer (50 mM HEPES pH
7.5, 100 mM KAc, 150 mM NaCl, 2 mM MgCl2, 1 mM EGTA,
0.5% [v/v] NP-40, 1 mM DTT, 5% [v/v] glycerol and Roche
Complete Protease Inhibitors) and homogenized using a
high-performance disperser (Fisher). The homogenate was
clarified by centrifugation at 750g for 20 min at 48C, and the
supernatant was incubated with 200 ml of anti-Flag M2 mag-
netic beads (Sigma-Aldrich) for 2–4 h on a rotating wheel at
48C. Beads were then washed four times in 10 ml of extraction
buffer for 5 min on a rotating wheel, transferred to a new tube
and washed one more time in 10 ml of PBS. Proteins were
eluted from beadswith 0.5 MNH4OHand 0.5 mMEDTA, con-
centrated, acetone precipitated and analysed by LC–MS/MS.
For the identification of CHMP4C interactors, the raw
MS data were analysed using the MASCOT search engine
(http://www.matrixscience.com). Peptides were searched
against the UniProt human sequence database, and the follow-
ing search parameters were employed: enzyme specificity was
set to trypsin, a maximum of two missed cleavages were
allowed, carbamidomethylation (Cys) was set as a fixed modi-
fication, while oxidation (Met), phosphorylation (Ser, Thr and
Tyr) and ubiquitylation (Lys) were considered as variable
modifications. Peptide and MS/MS tolerances were set to
25 parts per million (ppm) and 0.8 Da, respectively.
4.8. GFP pull-down assay
Cells stably expressing MKLP1::GFP (a gift from M. Mishima,
University of Warwick, UK) were transfected with plasmids
encoding Flag-tagged CHMP4C-WT or the two mutant var-
iants S210A and STripleA and synchronized in telophase as
described in the previous section. Cells were then collected
and stored at 2808C. The cell pellet was resuspended in
0.5 ml of extraction buffer (50 mM HEPES pH 7.5, 100 mM
KAc, 50 mM KCl, 2 mM MgCl2, 2 mM EGTA, 0.1% NP-40,
5 mM DTT, 5% glycerol and Roche Complete Protease Inhibi-
tors) and homogenized using a high-performance disperser
(Fisher). Homogenates were centrifuged at 2000 r.p.m. at 48C
in an Eppendorf 5417R centrifuge for 10 min and supernatants
transferred into new tubes. GFP-Trap-MADynabeads (25 ml;
Chromotek) was added to the supernatants and incubated
for 2 h on a rotating wheel at 48C. Beads were then washed
five times for 5 min in 0.5 ml of extraction buffer. Proteins
were eluted from beads with 0.5 ml of elution buffer (0.5 M
NH4OH and 0.5 mM EDTA pH 8.0), lyophilized and resus-
pended in Laemmli SDS–PAGE sample buffer (Sigma) and
boiled for 10 min. Proteins were separated on an SDS–PAGE
gel, transferred onto a PVDF membrane and probed to detect
GFP and Flag antibodies.
4.9. In vitro binding assay
DNA fragments coding for CHMP4C and MKLP1 fragments
were generated by PCR and cloned into pDEST15 (Thermo),
using Gateway technology to express N-terminal GST-tagged
polypeptides in E. coli. The GST-tagged products were then
rsob.royalsocietypublishing.org
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turer’s instruction (GE Healthcare). [35S] Methionine-labelled
CHMP4C andMKLP1 polypeptides were prepared from corre-
sponding PCR products amplified, using primers harbouring a
T7 promoter and then transcribed and translated in vitro using
the TnT T7 Quick Coupled Transcription/Translation System
(Promega) in the presence of [35S] methionine (Perkin Elmer).
The binding reaction contained 150 mM NaCl and subsequent
washes varied from 150 mM to 1 M NaCl. GST pull down
assays were carried out as described previously [37].
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